These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 15742902)

  • 1. Ochratoxin A: the continuing enigma.
    O'Brien E; Dietrich DR
    Crit Rev Toxicol; 2005 Jan; 35(1):33-60. PubMed ID: 15742902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ochratoxin A: An overview on toxicity and carcinogenicity in animals and humans.
    Pfohl-Leszkowicz A; Manderville RA
    Mol Nutr Food Res; 2007 Jan; 51(1):61-99. PubMed ID: 17195275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic pathways of ochratoxin A.
    Wu Q; Dohnal V; Huang L; Kuča K; Wang X; Chen G; Yuan Z
    Curr Drug Metab; 2011 Jan; 12(1):1-10. PubMed ID: 21222585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further arguments in favour of direct covalent binding of Ochratoxin A (OTA) after metabolic biotransformation.
    Pfohl-Leszkowicz A; Castegnaro M
    Food Addit Contam; 2005; 22 Suppl 1():75-87. PubMed ID: 16332625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex- and strain-specific induction of renal tumors by ochratoxin A in rats correlates with DNA adduction.
    Castegnaro M; Mohr U; Pfohl-Leszkowicz A; Estève J; Steinmann J; Tillmann T; Michelon J; Bartsch H
    Int J Cancer; 1998 Jul; 77(1):70-5. PubMed ID: 9639396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ochratoxin A in human kidney diseases.
    Fuchs R; Peraica M
    Food Addit Contam; 2005; 22 Suppl 1():53-7. PubMed ID: 16332622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ochratoxin A: 50 Years of Research.
    Malir F; Ostry V; Pfohl-Leszkowicz A; Malir J; Toman J
    Toxins (Basel); 2016 Jul; 8(7):. PubMed ID: 27384585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicokinetics and toxicodynamics of ochratoxin A, an update.
    Ringot D; Chango A; Schneider YJ; Larondelle Y
    Chem Biol Interact; 2006 Jan; 159(1):18-46. PubMed ID: 16293235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ochratoxin A exposure biomarkers in the Czech Republic and comparison with foreign countries.
    Malir F; Ostry V; Pfohl-Leszkowicz A; Roubal T
    Biomarkers; 2012 Nov; 17(7):577-89. PubMed ID: 22642623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex- and strain-specific expression of cytochrome P450s in ochratoxin A-induced genotoxicity and carcinogenicity in rats.
    Pfohl-Leszkowicz A; Pinelli E; Bartsch H; Mohr U; Castegnaro M
    Mol Carcinog; 1998 Oct; 23(2):76-85. PubMed ID: 9808161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ochratoxin A and human chronic nephropathy in Tunisia: is the situation endemic?
    Abid S; Hassen W; Achour A; Skhiri H; Maaroufi K; Ellouz F; Creppy E; Bacha H
    Hum Exp Toxicol; 2003 Feb; 22(2):77-84. PubMed ID: 12693831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ochratoxin A: induction of (oxidative) DNA damage, cytotoxicity and apoptosis in mammalian cell lines and primary cells.
    Kamp HG; Eisenbrand G; Schlatter J; Würth K; Janzowski C
    Toxicology; 2005 Jan; 206(3):413-25. PubMed ID: 15588931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ochratoxin A: previous risk assessments and issues arising.
    Walker R; Larsen JC
    Food Addit Contam; 2005; 22 Suppl 1():6-9. PubMed ID: 16332615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ochratoxin A as a potential etiologic factor in endemic nephropathy: lessons from toxicity studies in rats.
    Mally A; Hard GC; Dekant W
    Food Chem Toxicol; 2007 Nov; 45(11):2254-60. PubMed ID: 17629386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analyses of DNA adducts formed by ochratoxin A and aristolochic acid in patients with Chinese herbs nephropathy.
    Arlt VM; Pfohl-Leszkowicz A; Cosyns J; Schmeiser HH
    Mutat Res; 2001 Jul; 494(1-2):143-50. PubMed ID: 11423353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ochratoxin A induces oxidative DNA damage in liver and kidney after oral dosing to rats.
    Kamp HG; Eisenbrand G; Janzowski C; Kiossev J; Latendresse JR; Schlatter J; Turesky RJ
    Mol Nutr Food Res; 2005 Dec; 49(12):1160-7. PubMed ID: 16302199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ochratoxin a: general overview and actual molecular status.
    el Khoury A; Atoui A
    Toxins (Basel); 2010 Apr; 2(4):461-93. PubMed ID: 22069596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotoxic activity of ochratoxin A.
    Al-Anati L; Petzinger E
    J Vet Pharmacol Ther; 2006 Apr; 29(2):79-90. PubMed ID: 16515661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA adduct formation by ochratoxin A: review of the available evidence.
    Mally A; Dekant W
    Food Addit Contam; 2005; 22 Suppl 1():65-74. PubMed ID: 16332624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ochratoxin A: Toxicity, oxidative stress and metabolism.
    Tao Y; Xie S; Xu F; Liu A; Wang Y; Chen D; Pan Y; Huang L; Peng D; Wang X; Yuan Z
    Food Chem Toxicol; 2018 Feb; 112():320-331. PubMed ID: 29309824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.